OpenAI acquires startup Orchestra Bio to beef up its biotech business
OpenAI says it's adding Orchestra's team and technology to work on Rosalind, its AI model for life sciences research, and to its related Rosalind Workbench tool, a harness that aims to help researchers plan experiments and analyze results.
Buy One Founder Summit Ticket, Get a Second for Free. Register now.
Disrupt doors open Oct. 13. Get your pass and bring someone with you at 50% off. REGISTER NOW.
TechCrunch Desktop Logo TechCrunch Mobile Logo Latest Startups Venture Apple Security AI Apps Disrupt 2026 Events Podcasts Newsletters Search Submit Site Search Toggle Mega Menu Toggle Topics Latest
OpenAI on Tuesday acquired a four-year-old AI biotech software startup called Orchestra Bio, the company announced via its website. Terms of the deal were not disclosed, but the startup had reportedly raised around $20 million as of 2025 from backers like Andreessen Horowitz, Atria, and 8VC.
Orchestra creates AI agents that help biotech companies manage the minutiae of drug discovery operations, from tracking finances to resolving scheduling issues with clinical trials.
OpenAI says it’s adding Orchestra’s team and technology to work on Rosalind, its AI model for life sciences research, and to its related Rosalind Workbench tool, a harness that aims to help researchers plan experiments and analyze results. OpenAI has already won some big names as customers for Rosalind, including, it says, Moderna and Novo Nordisk.
The acquisition is a classic example of how the biggest AI labs (namely OpenAI and Anthropic) are building ever more software for the biggest industries, like pharma. In the startup world, there is an ongoing fear that at any moment, the labs will launch new features and become competitors. In this case, Orchestra is getting absorbed, rather than stomped out.
Buy One Pass, Get a Second Free Cover more ground at TechCrunch’s ultimate founder bootcamp of the year by bringing your co-founder or partner for free Book before the BOGO deal expires
Subscribe for the industry’s biggest tech news
Every weekday and Sunday, you can get the best of TechCrunch’s coverage.
TechCrunch Mobility is your destination for transportation news and insight.
Startups are the core of TechCrunch, so get our best coverage delivered weekly.
Provides movers and shakers with the info they need to start their day.
By submitting your email, you agree to our Terms and Privacy Notice.
OpenAI acquires startup Orchestra Bio to beef up its biotech business Julie Bort 20 seconds ago AI Google has joined Amazon in attacking Nvidia’s stronghold with AI app developers Julie Bort 2 hours ago AI ChatGPT now lets you lock your chats Aisha Malik 2 hours ago X LinkedIn Facebook Instagram youTube Mastodon Threads Bluesky TechCrunch Staff Contact Us Advertise Site Map Terms of Service Privacy Policy RSS Terms of Use Code of Conduct Voice AI Anthropic Flock Startup Battlefield Disrupt 2026 Tech Layoffs ChatGPT © 2026 TechCrunch Media LLC.